Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical CEO Roundtable on Cancer Inc.

CEO Roundtable on Cancer Inc.

Fiscal year ending 2024. Filed on June 16, 2025.

1204 Village Market Place 288
Morrisville, North Carolina 27560

CEO Roundtable on Cancer Inc. (EIN: 65-1230448) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, CEO Roundtable on Cancer Inc., a 501(c)(3) charitable organization, reported compensation for 4 out of 9 total employees. Among the employees shown here, the average compensation is $270,881. The highest compensated employee at CEO Roundtable on Cancer Inc. is Sean Khozin with fiscal year 2024 compensation of $421,402.

Revenue, expenses, and employee compensation

Revenue

$782,196

Expenses

$1,841,661

Employee compensation

$1,144,163
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Sean Khozin
Chief Executive Officer
$421,402
$416,369 No related comp$5,033
Marylisabeth Rich
President
$306,519
$277,551 No related comp$28,968
Julie Miller
ED Finance and HR
$190,041
$158,957 No related comp$31,084
Joya Harris
ED GOLD Standard
$165,561
$136,697 No related comp$28,864

Benchmark Employee Compensation

Non-Employee Board Members

Christopher Viehbacher
Member
David Reese
Member
James Goodnight
Member
John Crumpler
Member
Major General Elder Granger, M.D.
Member
Norman Sharpless
Member
Peter Guenter
Member
Peter Pisters
Member
Scott White
Member

Mission Statement

THE MISSION OF THE CEO ROUNDTABLE ON CANCER IS TO MAKE CONTINUAL PROGRESS TOWARD THE ELIMINATION OF CANCER AS A PERSONAL DISEASE AND PUBLIC HEALTH PROBLEM THROUGH INITIATIVES THAT REDUCE THE RISK OF CANCER, ENABLE EARLY DIAGNOSIS, FACILITATE ACCESS TO TREATMENT, AND HASTEN THE DISCOVERY OF EFFECTIVE THERAPIES.

Revisions to this organization profile

June 16, 2025:
2024 CEO Roundtable on Cancer Inc. 990 filed
December 20, 2024:
2023 CEO Roundtable on Cancer Inc. 990 filed
November 15, 2023:
2022 CEO Roundtable on Cancer Inc. 990 filed

Get an email when new compensation information is released for CEO Roundtable on Cancer Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →